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OPEN SCIENCE: OPEN SOURCE LICENSES IN SCIENTIFIC
RESEARCH
Andris Guadamuz Gonzdlez'
In recent years, there has been growing interest in the area of
open source software ("OSS") as an alternative economic model.
However, the success of the OSS mindshare and collaborative
online experience has wider implications to many other fields of
human endeavor than the mere licensing of computer programmes.
There are a growing number of institutions interested in using OSS
licensing schemes to distribute creative works and scientific
research, and even to publish online journals through open access
("OA "') licenses. There appears to be growing concern in the
scientific community about the trend to fence and protect scientific
research through intellectual property, particularly by the abuse of
patent applications for biotechnology research. The OSS
experience represents a successful model which demonstrates that
IP licenses could eventually be used to protect against the misuse
and misappropriation of basic scientific research. This would be
done by translating existing OSS licenses to protect scientific
research. Some efforts are already paying dividends in areas such
as scientific publishing, evidenced by the growing number of OA
journals. However, the process of translating software licenses to
areas other than publishing has been more difficult. OSS and OA
licenses work best with works subject to copyright protection
because copyright subsists in an original work as soon as it is
created However, it has been more difficult to generate a license
that covers patented works because patents are only awarded
through a lengthy application and registration process. If the open
science experiment is to work, it needs the intervention of the legal
community to draft new licenses that may apply to scientific
research. This article will look at the issue of such OA licenses,
1 Lecturer, University of Edinburgh, and co-director of The Arts and
Humanities Research Council Centre for Studies in Intellectual Property and
Technology Law at the University of Edinburgh.
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paying special care as to how the system can best be exported to
scientific research based on OSS and OA ideals.
I. INTRODUCTION
Recent years have witnessed an increase in the quantity and
quality of studies dedicated to the economics of research and
development for science and technology, 2 with particular interest
paid to the economic study of the impact of intellectual property
rights in the fostering of innovation.3 Intellectual property ("IP")
has been considered one of the most important drivers of new
innovation in science and technology because it allows researchers,
institutions, and inventors to recover their investment in the shape
of limited monopolies to their ideas.' However, some authors have
raised concerns that enhanced intellectual property protection may
actually have adverse effects in the development of future
research.' Basic research had usually not been considered to be
subject to protection, and up until recently it was generally offered
to the public in the shape of peer-reviewed journals. However,
there is a growing trend towards excessive commercialisation and
protection of scientific data, as illustrated in the case of the
growing protection of the human genome. 6
2 See, e.g., M. P. FELDMAN, A. N. LINK & D. S. SIEGEL, THE ECONOMICS OF
SCIENCE AND TECHNOLOGY: AN OVERVIEW OF INITIATIVES TO FOSTER
INNOVATION, ENTREPRENEURSHIP, AND ECONOMIC GROWTH (Kluwer Academic
2002).
3 See OVE GRANSTRAND, THE ECONOMICS AND MANAGEMENT OF
INTELLECTUAL PROPERTY: TOWARDS INTELLECTUAL CAPITALISM (Edward
Elgar ed., 1999); KEITH E. MASKUS, INTELLECTUAL PROPERTY RIGHTS IN THE
GLOBAL ECONOMY (Institute for International Economics 2000).
4 See, e.g., Edwin Mansfield, Patents and Innovation: An Empirical Study, 32
MGMT. SCI. 173 (1986).
5 Steve Bunk, Researchers Feel Threatened by Disease Gene Patents, 13 THE
SCIENTIST 7 (1999); J. H. Reichman & Paul F. Ulhir, Database Protection at the
Crossroads: Recent Developments and Their Impact on Science and
Technology, 14 BERKELEY TECH. L.J. 793 (1999).
6 John Sulston, Intellectual Property and the Human Genome, in GLOBAL
INTELLECTUAL PROPERTY RIGHTS: KNOWLEDGE, ACCESS, AND DEVELOPMENT
61-73 (Peter Drahos & Ruth Mayne eds., 2002).
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Because access to scientific data has become a requisite of
modem research and development ("R&D"), there is growing
concern that the trend towards commercialisation will translate into
less available public academic research, which would therefore
reduce the overall scientific output. These worries have prompted
several studies and reports that attempt to address the problem of
the dissemination of academic scientific research.7 The area of
biotechnology has been deemed to be of particular concern
because of its significant economic potential; therefore, it has been
the subject of a patenting rush of unprecedented proportions.8 This
phenomenon has prompted the release of genetic information into
the public domain, which has also prompted fears of the misuse of
the publicly available data by unscrupulous users, who will use this
information to close and commodify research through excessively
general patents.
These problems have motivated some to call for the devising
and utilisation of new ways of protecting basic scientific research
from potentially damaging commodification of knowledge.9 One
proposed solution is to use the novel intellectual property licensing
model that has been successful in software development, generally
known as OSS. This system uses intellectual property protection
to ensure the wider dissemination of software, by maintaining the
copyright protection over a work, and then distributing it using a
license that allows further copying and redistribution of the work,
ensuring that the wider community will have access to the
7 See, e.g., An Economic Analysis of Scientific Research Publishing, A Report
Commissioned by the Wellcome Trust, Revised Edition (Oct. 2003),
http://www.wellcome.ac.uk/assets/wtd003182.pdf; House of Commons Science
and Technology Committee, Scientific Publications: Free for All?, 2003-4,
H.C. 399-I, http://www.publications.parliament.uk/pa/cm200304/cmselect/
cmsctech/399/399.pdf.
8 GRAHAM DUTFIELD, INTELLECTUAL PROPERTY RIGHTS AND THE LIFE
SCIENCE INDUSTRIES: A 20TH CENTURY HISTORY 51-74 (Ashgate Publishing
Limited 2003).
9 Stephen M. Maurer, New Institutions for Doing Science: From Databases
to Open Source Biology, paper presented to the European Policy for Intellectual
Property Conference on Copyright and database protection, patents and research
tools, and other challenges to the intellectual property system (Nov. 24-25,
2003), http://www.merit.unimaas.nl/epip/papers/maurer_paper.pdf.
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software's source code and allow its modification and
dissemination. There are several open source and free software
licensing models, but the common denominator in most of them is
to allow access to the source code and to allow users to
disseminate the code without restrictions."
It is with regards to scientific research and innovation that the
possibility of translating some of these open source models to the
scientific research arena comes into play. The initial application of
open source has been in the adoption of a scientific publishing
model often referred to as OA. The OA movement can best be
exemplified by the publication of scientific outputs and other
materials online." These results are offered online without
subscription charges, allowing the wider scientific community
access to high-quality content with the click of a button. However,
open access is not enough to ensure access to scientific works
because OA generally covers only those materials that are subject
to copyright protection, such as journal articles. If scientists want
to distribute their works using the open source model, then there
would need to be some sort of license that allows the distribution
of patented works, or works contained in scientific databases.
The solution would appear to be a simple matter of translating
existing licenses to protect patented research, but this has proven to
be much harder than previously expected. It is very interesting
that while there are new OA and open source licenses created
every day, an open science license that protects research through
patents and database rights has been slow in the making, despite
10 Andres Guadamuz, Viral Contracts or Unenforceable Documents?
Contractual Validity of Copyleft Licenses, 26 EUR. INTELL. PROP. REv. 331
(2004).
" Berlin Declaration on Open Access to Knowledge in the Sciences and
Humanities, Conference on Open Access to Knowledge in the Sciences and
Humanities (Oct. 20-22, 2003), http://www.zim.mpg.de/openaccess-berlin/
berlindeclaration.html.
12 Kenneth Neil Cukier, Open Source Biotech: Can a Non-Proprietary
Approach to Intellectual Property Work in the Life Sciences? 1 THE ACUMEN J.
LIFE SCI. (2003), available at http://www.cukier.com/writings/
opensourcebiotech.html.
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the obvious enthusiasm from commentators, and extensive political
will to generate such a license."
There are many reasons for the difficulties encountered. Some
have pointed out that the open source model does not work best
with patented works, 4 because the model appears to be in conflict
with the public interest justifications for patents, which imply that
inventors are expected to recoup the investment they have
incurred. It has also been remarked that the open source model
works best with copyright works because they protect creations
that are immediately awarded protection, while patented research
requires a specific application to the research, making its
dissemination through open licenses a more difficult endeavor.
The present article tries to respond and contribute to these
developments by examining of the existing scheme to determine
the efficacy of the movement and its application to all sorts of
scientific research outputs. Then, the paper will present a
suggestion for a new licensing model for patentable scientific
research that allows access and dissemination to diverse fields of
endeavor.
II. WHAT IS OPEN SOURCE?
There is considerable discussion about the different definitions
and variations of what is generally understood as open source
software, particularly because there is currently a divergence of
opinion between different camps in whether one should use the
terms "open source" or "free software" to define the movements
implicit in the permissive distribution of software. 5 This is not the
13 Dan Burk, Open Source Genomics, 8 B.U.J. SCI. & TECH. L. 254 (2002).
14 Robin Cooper Feldman, The Open Source Biotechnology Movement: Is It
Patent Misuse? (2004) (unpublished manuscript, on file with Vol. 6 of
MINNESOTA JOURNAL OF LAW, SCIENCE & TECHNOLOGY), available at
http://papers.ssm.con/sol3/papers.cfm?abstractid=545082.
15 For one side of the debate, see Richard Stallman, Why "Free Software" is
better than "Open Source" (1998), http://www.gnu.org/philosophy/free-
software-for-freedom.html. This dispute has been exacerbated by the release of
the latest version (version 3) of the influential General Public License ("GPL").
There seems to be a final split in the making between the open source and free
SPRING 2006] 325
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place to solve this dispute, but it should be said that agreeing on
the terms is of significant importance to the nascent movement.
Suffice it to say, there are different terms that can be used to
describe the movement: Free Software ("FS"), Open Source
Software ("OSS"), Free Open Source Software ("FOSS"), Free
Libre Open Source Software ("FLOSS"), Open Code,16 and non-
proprietary software.' 7 The reason behind the many different terms
and definitions is mostly historical, and comes from the fact that
each denomination, particularly FS and OSS, have become
attached with specific philosophies and ideologies, and, moreover,
each of these definitions will usually inform the type of licenses
used to distribute the work." This work will use the term "open
source software" when talking specifically about the many
different licenses used in software development.
In its widest possible sense, OSS is used to define a computer
program that allows later modifications by the user or other
developers by providing access to its source code 9 through the use
of a permissive license. In this light, non-proprietary software is
considered as such if it "is released with a license that would
permit others to 'fork' the software and release their own modified
versions without onerous restrictions, even though the copyright
may remain in the hands of a single individual. At least in theory,
control has been conceded."2
software camps because Linus Torvalds has decided not to adopt the new
version in the Linux Kernel. For an earlier discussion about the GPL v3, see
Robert W. Gomulkiewicz, General Public License 3.0: Hacking the Free
Software Movement's Constitution, 42 Hous. L. REv. 1015 (2005).
16 This is the term preferred by Lessig to avoid the FS/OSS debate. See
LAWRENCE LESSIG, CODE AND OTHER LAWS OF CYBERSPACE 7 (Basic Books
2000).
17 This term is the term preferred by the author. See Guadamuz, supra note
10, at 332.
18 LAWRENCE E. ROSEN, OPEN SOURCE LICENSING: SOFTWARE FREEDOM AND
INTELLECTUAL PROPERTY LAW 51-69 (1 st ed. 2004).
19 "Source code" are the programming statements in a programming language
that exist before the program is compiled into an executable application. The
executable form of the software is generally known as the object code, and can
only be read by the machine.
20 Wikipedia.com, Proprietary Software (2002), http://en.wikipedia.org/wiki/
proprietary_software.
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Beyond this basic definition, there are a few differences
between the other terms, but they are generally referring to some
core principles. In the strictest sense, the FS concept is centred on
the idea of developing programs and distributing them freely.'
Stallman defines free software as having four basic freedoms: the
freedom to run the program; the freedom to study how the program
works by giving access to the source code; the freedom to
redistribute copies; and the freedom to improve and distribute
improvements to the public.22 As understood by the proponents of
free software, programmers and other developers can charge for
the software if it is their desire to do so, but the same underlying
freedom behind the software must exist either if it is acquired for a
fee or if it is not. The user must still be able to have all of the
freedoms described, with access to the source code as the most
basic requisite. 3
These freedoms are protected by the adoption of a restrictive
licensing model that makes use of existing copyright legislation
that guards the source code from proprietary software developers
who want to copy it, adapt it and include it in their own programs.
This licensing model is exemplified in the General Public License("6GPL").2
Open source is closely related to Free Software development,
but it does contain a different emphasis about the freedoms
involved. The term open source was coined during a strategy
meeting in February 1998 in Palo Alto California by a group of
software developers with links to the Linux operating system.25
The need to create a new term to define this viewpoint had become
evident because, until then, the prevalent way to describe all output
21 Tony Stanco, We are the New Guardians of the World (2001),
http://lwn.net/2001/0531/a/guardians.php3. It is vital to note that the meaning of
the word "free" in FS does not mean free as in having no price, but rather free as
in "freedom," or as it is often stated in OS and FS circles, free must be
understood as in freedom, not as in beer.
22 The Free Software Definition, http://www.fsf.org/philosophy/free-sw.html.
23 Selling Free Software, http://www.gnu.org/philosophy/selling.html.
24 The text of the GPL can be found at http://www.gnu.org/copyleft/gpi.html.
25 Open Source Initiative, History of the OSI, http://www.opensource.org/
docs/history.html.
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produced by the non-proprietary approach was by using the
expression "free software," based mostly on the FS philosophy
described. It was apparent to many software developers that this
movement had a tarnished reputation in the business world as a
result of the more radical ideas held by people linked to the FS.
Open Source then is the opposite of "closed source," the traditional
proprietary approach to software development in the commercial
world. Closed source is software "in which the customer gets a
sealed block of bits which cannot be examined, modified, or
evolved."26  The main idea behind open source is to provide
software for which the source is available for examination,
modification and peer-review. The official definition of OSS came
out of the original meeting, and was based on the Debian Free
Software Guidelines, a licensing model that accompanies the
Debian GNU/Linux system, a Linux distribution.27 This has
generated an Open Source Definition ("OSD"), which includes a
recommended set of clauses that an OSS license should contain.
These licenses are exemplified by the Berkley Software
Distribution ("BSD"), the Apache License and the Mozilla Public
License ("MPL").29
Ill. THE OPEN SCIENCE MOVEMENT
It has become increasingly common to see the term "open
source" used to describe all sorts of fields of study outside of the
software arena that gave rise to the concept.3" The application of
this term to other fields could be loosely described as the open
licensing movement, which can be defined as the distribution of
works protected through intellectual property with the use of
26 Keeping an Open Mind (Nov. 11, 2000), http://www.catb.org/-esr/
writings/openmind.html.
27 The guidelines can be found at http://www.debian.org/social-contract.html
#guidelines.
28 The OSD can be found at Open Source.org, The Open Source Definition,
http://www.opensource.org/docs/definition.php.
9 A list of approved licenses can be found at http://www.opensource.org/
licenses/.
30 See, e.g., Sara Boettiger & Dan Burk, Open Source Patenting, 1 J. INT'L
BIOTECHNOLOGY L. 11 (2004); Burk, supra note 13.
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permissive "some rights reserved" licenses based on the principles
reflected in open source licenses and definitions. Given the varied
choice of terminology encountered in software development, the
new licensing scheme could also receive different names, such as
non-proprietary licenses, free licenses, or commons licenses.
However, the preferred word to describe this disparate movement
seems to be the use of the term "open." Superficially, there seems
to be a good argument to choose the term "open source," as it is
the one that is more readily identifiable by the public as a
description of non-proprietary software models. 3' However, the
term "open source" is problematic because the open source
paradigm may not translate well into other fields because the
original term was used to describe the availability of a computer
programme's source code. Therefore, open source should not be
used to identify licensing schemes that do not refer to software at
all, and where there is no source code to be open. For example, a
recent article in The Economist asks: "What does it mean to apply
the term 'open source' in fields outside software development,
which do not use 'source code' as a term of art? Depending on the
field in question, the analogy with source code may not always be
appropriate. 32
Despite these misgivings, there would appear to be almost
universal agreement about using the word "open" to describe a
philosophical movement that shares the principles and objectives
of the two main non-proprietary software camps. The use of these
ideals in the area of scientific research presents the birth of a new
movement that could be called "open science." This movement
could be defined as the application of open source licensing
principles and clauses to protect and distribute the fruits of
scientific research. This can be done by applying the OSS model
to protect other works in areas as varied as biotechnology,
biodiversity databases, traditional knowledge, and medical
research. Non-proprietary and OA models would be an excellent
31 As a measure of the prevalence of open source over other terms, Google
throws 337,000 results for "non-proprietary," 19,000,000 results for "free
software," and 23,600,000 for "open source."
32 An open-source shot in the arm? ECONOMIST, June 10, 2004, available at
http://www.economist.com/displaystory.cfm?storyid=2724420.
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option to maintain a body of technological knowledge that can be
shared without fear of misappropriation by commercial interests,
access to the protected technologies. According to Maurer, open
science is thus defined: "Open science is variously defined, but
tends to connote (a) full, frank, and timely publication of results,
(b) absence of intellectual property restrictions, and (c) radically
increased pre- and post-publication transparency of data, activities,
and deliberations within research groups."33
The suggested definition of open science can be used to cover
the many different types of scientific outputs described, but there
are two main areas of output that are being discussed in the
literature as subject to the potential adoption of open licenses.
These are the scientific publishing and the scientific output, such
as databases and patented inventions. The first is embodied in the
open access movement; the second is better exemplified in the so-
called open biotechnology movement.
A. Open Access
The term "open access" has become prevalent in the literature
in recent years to identify works that are freely available over the
internet (using free in the "freedom" sense). These works will
generally be distributed by maintaining their copyright-although
the term should be generic enough to define works that have been
released into the public domain. OA then will be any work that
has been offered under a permissive license that allows the
redistribution of the work.
More specifically, OA has gained some very specific
connotations because it is used to refer to academic journals and
some forms of academic publication through the use of such
licenses. This is evidenced by the many different conferences and
symposia that have been organised to provide a theoretical
framework to OA, which has resulted in the influential Berlin
Declaration on Open Access to Knowledge in the Sciences and
Humanities,34 the Budapest Open Access Initiative ("BOAI"),35 the
33 Maurer, supra note 9.
34 The full text of the declaration can be found at http://www.zim.mpg.de/
openaccess-berlin/berlindeclaration.html.
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Bethesda Statement on Open Access Publishing,36 and also the
European Cultural Heritage Online ("ECHO") Charter.37 Of these,
one of the most cited definitions is that of the Berlin Declaration,
which defines open access as: "a comprehensive source of human
knowledge and cultural heritage that has been approved by the
scientific community .... Open access contributions include
original scientific research results, raw data and metadata, source
materials, digital representations of pictorial and graphical
materials and scholarly multimedia material."38
This definition is very narrow, as it only accepts as OA those
works approved by the scientific community, which seems to
imply that a form of peer-review is required. In similar fashion,
the BOAI defines OA in light of peer-reviewed and scholarly
publications, but it allows for the publishing of materials that have
not been reviewed for the purpose of comments. The BOAI states
that OA covers literature which is published in "peer-reviewed
journal articles, but it also includes any unreviewed preprints that
they might wish to put online for comment or to alert colleagues to
important research findings."39
Still, most of the definitions in the declarations tend to be very
narrow.4" Philosopher and OA advocate, Peter Suber, proposes a
more open definition, which states that:
"Open access" (OA) is free online access. OA literature is not only
free of charge to everyone with an internet connection, but free of most
copyright and licensing restrictions. OA literature is barrier-free
literature produced by removing the price barriers and permission
35 More about the initiative can be found at Budapest Open Access Initiative
("BOAI"), http://www.soros.org/openaccess.
36 See Bethesda Statement on Open Access Publishing, http://www.earlham.
edu/-peters/fos/bethesda.htm.
37 See European Cultural Heritage Online, http://www.ling.lu.se/projects/
echo/contributors/charter.html.
38 See Berlin Declaration on Open Access to Knowledge in the Sciences &
Humanities, supra note 11.
39 BOAI, supra note 35 (follow hyperlink "read the initiative").
40 For another narrow definition, see Directory of Open Access Journals
("DOAJ"), http://www.doaj.org/articles/questions#definition.
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barriers that block access and limit usage of most conventionally
published literature, whether in print or online.'
This definition tends to be more in line with the sharing ethos
42
that gives birth to open source software, and therefore it is more in
line with the intellectual, legal, and ideological parent of open
access. While it must be said that there is an argument to be made
in favour of quality control of scholarly research, the movement
could benefit from further dissemination of other content offered
online.
The growth of OA journals is undeniable. At the moment of
writing, the Directory of Open Access Journals ("DOAJ") 43 listed
almost 2000 OA journals in all categories of scientific research,
with estimates that at least thirty new journals are being added to
the DOAJ every month. Figures such as these tend to indicate that
this model may very well be the future of academic publishing,
particularly for academic journals.
Initially, one could be suspicious about the academic and
economic viability of the model, but this is being disputed by the
existing research. Some studies, for example, indicate that journals
that are available online have wider circulation and are more cited
than more prestigious journals. A study of 119,924 conference
articles in computer science found that the most cited articles were
significantly most likely to come from journals available online
than from offline journals by an average of 336%.' Another study
in the United States has found that online journal publishing is
economically sustainable under the present system because the
revenue obtained by each published article from the publisher is
equal to the cost of producing the article, which removes the
economic recuperation justification. The study points out that
41 Peter Suber, Creating an Intellectual Commons through Open Access (May
28, 2004), http://dlc.dlib.indiana.edu/archive/00001246/01/suberrev052804.pdf.
42 See Andres Guadamuz, The 'New Sharing Ethic' in Cyberspace, 5 J.
WORLD INTELL. PROP. 129 (2002), http://papers.ssm.com/sol3/papers.cfm?
abstract id=5691 11.
43 See Nature WebDebates, http://www.doaj.org.
44 Steve Lawrence, Free online availability substantially increases a paper's
impact, NATURE (May 31 2001), available at http://www.nature.com/nature/
debates/e-access/Articles/lawrence.html.
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"[t]he monetary cost of the time that scholars put into the journal
business as editors and referees is about as large as the total
revenue that publishers derive from sales of the journals."45 This
statement is corroborated by more recent research that concludes
that open source journals are increasing in numbers because they
are able to be financed by different types of funding sources,
including author fees, conference hosting, and the provision of
value-added services.46
B. Open Biotechnology
One of the best areas to explore the open science movement is
the field of biotechnology research and the creation of open
biotechnology, which can be defined as a sub-section of open
science. To understand the application of open source models to
the field of biotechnology, one must understand the race to
sequence the human genome.47 During the 1990s, there were
several groups attempting to decode the human genome, but most
of the public efforts were brought together in 1996 with the
creation of the International Human Genome Sequencing
Consortium ("the Consortium"), a collection of researchers from
around the world.48 These efforts were geared towards the
principle of sharing the information obtained by the participants
with the common goal of classifying the totality of human genetic
sequences, exemplified by the "Bermuda Principles."49  The
Principles clearly specified that the results of the research would be
placed in the public domain as soon as possible. The Human
45 Andrew Odlyzko, The Economics of Electronic Journals, 2 FIRST MONDAY
(1997), available at http://firstmonday.org/issues/issue2_8/odlyzko/index.html.
46 John Willinsky, Scholarly Associations and the Economic Viability of Open
Access Publishing, 4 J. DIGITAL INFO. 177 (2003), available at http://research2.
csci.educ.ubc.ca/eprints/archive/00000004/0 1 /?printable=l.
47 For a comprehensive account of the race for the human genome, see
Sulston, supra note 6, at 61-73.
48 These included the Wellcome Trust, the UK Medical Research Council, the
U.S. National Center for Human Genome Research, the German Human
Genome Programme, the European Commission, the Human Genome
Organisation, and the Human Genome Project of Japan.
49 For a summary of both meetings, see Doegenomes.org, http://www.ornl.
gov/hgmis/research/bermuda.html.
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Genome Organisation ("HUGO") was made responsible for
coordinating the data and for using the internet for its release.
Despite the early spirit of sharing exemplified by the
Consortium and by the Bermuda Principles, some firms started
looking at the possibility of commercialising the results. In 1998,
a member of the Consortium created the company Celera
Genomics, which set off immediately to finish a sequence of the
human genome before the Consortium did.0 Celera eventually
would fail in achieving the full genome first, even though there
was growing suspicion that they were using parts of the publicly
made material by the Consortium in order to boost their research.
In the year 2000, a joint statement by the two participants was
made public, announcing that there was an initial draft of the full
human genome,5 l and the results from the public sector have
already been made public in several websites.5 2 However, in 2001
the contending parties published their respective results at the same
time, and while the Consortium claimed that Celera had copied
their published results, Celera refuted the claims. 3 Without going
into the details of these controversial claims and counter-claims, it
is clear that the race itself worried some public-sector researchers
about the possible abuse of publicly available information that
could be used later on to make broad patent claims and commodify
the biological data offered.54 This fear seemed to be corroborated
by the facts that by 1999, Celera had applied for the patenting of
50 Sulston, supra note 6, at 64-65.
51 Human Genome Project, International Human Genome Sequencing
Consortium Announces "Working Draft" of Human Genome, Human Genome
Project press release, June 2000, http://www.nih.gov/news/pr/jun2000/nhgri-26.
htm.
52 A good collection of these can be found at http://www.ensembl.org/
index/html.
53 To contrast both views, see R. Waterston, E. Lander & J. Sulston, On the
sequencing of the human genome, 99 PROC. NAT'L ACAD. ScI. 3712 (2002); E.
Myers et al., On the sequencing and assembly of the human genome, 99 PROc.
NAT'L ACAD. SCI. 4145 (2002).
54 Ken Howard, The Bioinformatics Gold Rush, 283 SCI. AM. 58 (2000),
available at http://www.cvcaroyals.org/-rluker/pdf files/GenomicBusiness.
pdf.
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6500 human gene sequences, and by 2000 it had been awarded 300
patents."
The state of affairs in biotechnology patenting generates
considerable problems for those involved in this area, as excessive
patenting threatens to hinder collaboration and research
considerably because it generates an environment where
researchers live in constant fear of litigation. A study conducted in
2002 found that researchers working in the area of genetics have
significantly reduced normal academic collaboration practices due
to fears about patent infringement, amongst other reasons. 6
Similarly, overly broad gene patents could be used to attempt
to gain a foothold in the market and stifle competition in the
nascent biotechnology industry. Small research centres,
educational institutions, and individual researchers may find it
difficult to conduct research for fear of becoming involved in
costly patent litigation. Moreover, even if a biotechnology patent
has been erroneously granted, stakeholders and researchers would
still need to get involved in a lengthy procedure to cancel the
invalid patent, further stifling research.57 A decrease in the practice
of sharing biotech research could have nefarious consequences to
the field, as the exchange of data held in different databases could
be hindered. 8
This is where open biotechnology has been suggested as a
possible tool to foster the exchange of research and the transfer of
technology amongst researchers all over the world. The general
idea behind open biotechnology is to protect the fruits of scientific
research by using non-proprietary licenses-particularly copyleft
ones. The research would be made available to the public online
55 Heather Kent, Benefits of genetic research must be shared, international
genome organization warns, 162 CANADIAN MED. ASS'N J. 1736 (2000),
available at http://www.cmaj.ca/cgi/reprint/1 62/12/1736.
56 D. Blumenthal et al., Data Withholding in Academic Genetics, 287 J. AM.
MED. ASS'N. 477 (2002).
57 L. Andrews, The Gene Patent Dilemma: Balancing Commercial Incentives
With Health Needs, 2 Hous. J. HEALTH L. & POL'Y 65 (2002).
58 Nicholas Thompson, May the Source Be With You, WASHINGTON
MONTHLY, (July/Aug. 2002), http://www.washingtonmonthly.com/features/
2001/0207.thompson.html.
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with an attached license that allows further uses of the material, but
forbids the commercialisation of the research by threatening to
enforce the intellectual property rights that protect them. This
strategy would be compatible with the existing ethos of sharing
research that exists in the scientific community. Talking about the
possible use of the open source model in the field of
bioinformatics, scientist Ewan Birney from the European
Bioinformatics Institute commented that "[f]or us, it's straight
scientific principles. If you want to be a scientist, open up your
data and open up the code that helps you work with that data."59
The first effort to implement this idea was undertaken by Tim
Hubbard of the Sanger Institute in the United Kingdom, which was
involved in the Human Genome Project. Hubbard became
interested in open source and open content licenses, until he
realised that the model could be used to protect human genome
research.6 ° Although Hubbard drafted a license, the idea was never
implemented by the Sanger Institute because all of the materials
were being released into the public domain and could not be
licensed. John Sulston, a prominent voice in the genetic research
community, has provided some sobering comments about the fact
that protecting scientific works intended for public dissemination
with a license is contrary to the ethos behind such undertaking.6
The idea is to make the works available to the public, not to tie
them up in legal battles and complex patent suits.
After this initial disappointment, there have been a few other
suggestions about the use of the OSS model to protect the public
results of the biotechnology research, although the implementation
of such ideas has been minimal.62 The failure to produce a viable
movement is made more evident when the open biotechnology
idea is contrasted with the aforementioned open source software
and OA models, which have been hugely successful by all
59 Sam Williams, I Hack the Body Electric, O'REILLY NETWORK, (July 25
2002), http://www.oreillynet.com/lpt/a/2580.
60 Cukier, supra note 12.
61 Sulston, supra note 6, at 64.
62 Burk, supra note 13.
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measures. 63  In contrast, the implementation of an open
biotechnology or open health license has been slow. There is no
shortage of suggestions and positive press about the possibilities of
open biotechnology, but these have not produced particularly
concrete efforts.64
Nevertheless, there is one particular area of open
biotechnology that has been successful, and that is the area of
bioinformatics. Bioinformatics is the application of information
technology to solve biological problems.65 Bioinformatics projects
can use all sorts of software, but it has been increasingly likely to
see open source software as a favoured tool. 66 Nevertheless, the
relative success of bioinformatics has more to do with the success
of open source software than with the application of open
biotechnology.
Another success story in open science is the Center for the
Application of Molecular Biology to International Agriculture
("CAMBIA"),67 which is an organisation that is attempting to solve
many of the problems open science has faced by the judicious use
of intellectual property "work-arounds" in the areas of agriculture,
food security, biotechnology, and the environment. 68 This is done
through several IP specific proposals:
63 For more about the success of the movement, see STEVEN WEBER, THE
SUCCESS OF OPEN SOURCE (Harvard Univ. Press 2004).
64 See, e.g., R. Carlson, Open-Source Biology and Its Impact on Industry,
SPECTRUM ONLINE, (May 2004), http://www.kurzweilai.net/meme/
frame.html?main=/articles/art0613.html.
65 Wikipedia.com, "Bioinformatics," http://en.wikipedia.org/wiki/
Bioinformatics.
66 See, e.g., S. Dudoit, R.C. Gentleman & J. Quackenbush, Open source
software for the analysis of microarray data, 34 BIOTECHNIQUES S45 (2003),
available at http://papakilo.icmb.utexas.edu/cshl-2005/papers/Sandrine_
bioconductor.pdf; T. Hubbard et al., The Ensembl genome database project, 30
NUCLEIC ACIDS RES. 38 (2002), available at http://nar.oxfordjournals.org/cgi/
reprint/30/1/38.
67 The centre can be found at http://www.cambia.org.
68 C. Dennis, Biologists launch 'open-source movement,' 431 NATURE 494
(2004).
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(1) A portal called Biological Innovation for the Open
Society ("BiOS"), which brings together a number of open
biotechnology efforts.69
The BiOS patent database includes 1,500,000 life-science
patents from the different jurisdictions, which will allow
researchers to look for possible patented materials in their
area of research, allowing them to avoid costly litigation at
a later date.7°
(2) CAMBIA has applied and obtained twelve patents of
biologic material in different patent offices around the
world.7
(3) Bioinformatics tools offered through a research portal
called BioForge.72  This repository will host diverse
projects that operate in a similar manner to open source
software projects, providing a place to bring together
researchers.
This is an encouraging step that will hopefully reverse the
relative slow rate of progress in open biotechnology. This is
because there are now some workable licenses within the BiOS
project. These will be discussed in detail in the next section.
IV. THE LICENSING PARADIGM
One of the problems exposed by the open access debate is that
there is significant misuse and misunderstanding of the terms and
definitions involved. It is common to read terms such as "free
software," "commons," "open source," and "public domain"
interchangeably. There must be an understanding that besides the
ideological and philosophical connotations of each term, the heart
69 See CAMBIA, http://www.cambia.org/daisy/bios/home.html.
70 See CAMBIA, Patent Lens, http://www.cambia.org/daisy/patentlens/
patentlens.html.
71 CAMBIA, Intellectual Property, http://www.cambia.org/daisy/cambia/
intellectualproperty.html.
72 Based on the successful open source software project repository and portal
called SourceForge. BioForge can be found at https://www.bioforge.net/.
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of the movement is the distribution of intellectual works through
permissive licenses.
The open licensing model is centered on the licenses; without
them, the movement is just a project management technique. The
free software and open source software movements have shown
the way to follow regarding licensing agreements. The starting
point for non-software licenses will be to learn from the
experiences in non-proprietary software development." However,
there should be an understanding that these licenses are just a
starting point, as OSS licenses tend to be specific to software
development and, in many instances, they have been drafted by
software engineers with little or no intervention of the legal
community.74 Furthermore, some software developers appear to
display considerable reluctance about external intervention in the
decision process regarding licensing decisions.75 This section takes
a closer look at the attempts to translate the OSS ideals to the
needs of scientific research.
A. Open Access Licenses
Open access publishing tends to use "some rights reserved"
licenses in order to distribute the academic materials involved.
These may include the use of standard licenses, or in some
instances, it may include the use of customised licenses. At the
73 For literature that deals directly with FOSS licenses, see R. Gomulkiewicz,
De-Bugging Open Source Software Licensing, 64 U. PITT. L. REv. 75 (2002); D.
Ravicher, Facilitating Collaborative Software Development: The Enforceability
of Mass Market Public Software Licenses, 5 VA. J.L. & TECH. 11 (2000); D.
Kennedy, A Primer on Open Source Licensing Legal Issues: Copyright,
Copylefi and Copyfuture, 20 ST. LOUIS U. PUB. L. REv. 345 (2001), available at
http://law.slu.edu/joumals/plr.html; C. Nadan, Open Source Licensing: Virus or
Virtue, 10 TEX. INTELL. PROP. L.J. 349 (2002).
74 Richard Stallman is generally attributed as the author of the GPL, but
Professor Eben Moglen provided legal assistance. See GLYN MOODY, REBEL
CODE: LiNux AND THE OPEN SOURCE REVOLUTION 26 (Penguin 2002).
75 Prodromos Tsiavos, The (dis)illusions of a rebel: A reappraisal of the
General Public License through techno-organizational analysis, Presented at the
19th BILETA Annual Conference, University of Durham (Mar. 25-26, 2004).
SPRING 20061
N.C. J. L. & TECH.
time of writing, the most prevalent open access distribution scheme
is through Creative Commons ("CC") licenses."6
The Creative Commons project attempts to create so-called
"intellectual property conservancies,"77 separating a block of
human knowledge offered for the benefit of the public, but still
protected by intellectual property. This is analogous to nature
conservation areas that exist for the wider social benefit, but have
restrictions on certain uses. In the Creative Commons, the goal of
intellectual property conservancies is achieved through the offering
of a wide variety of licenses to protect creative works from misuse.
This is done through the application of open source principles,
where the work retains its copyright protection, but it is distributed
freely"8 as long as the conditions contained in the license are met.
The interesting part of the CC licensing environment is that it
empowers users because there is a wide range of licenses to choose
from. Creators and authors need only to go to a website and select
from different options offered in a few drop-down menus; the
system then chooses the license that fits the parameters entered.
These licenses range from offering the work straight into the public
domain, to more complex licenses with restrictions as to the
commercial distribution of the work and the use of licenses in such
distributions.79
Creative Commons licenses maintain a minimum set of
standards that are met by all of their offered legal documents, with
the exception of the one that offers the work to the public domain.
This could be called the Creative Commons Definition, but it is
76 For example, the Public Library of Science ("PLoS"), one of the largest
open access journal collections, is published through a CC license.
77 Creative Commons, Legal Concepts, http://creativecommons.org/learn/
legal/.
78 In the Free Software sense.
79 For more about Creative Commons, see Charlotte Waelde, et al., The
Common Information Environment and Creative Commons, Final Report to the
Common Information Environment Members of a study on the applicability of
Creative Commons Licences (2005), available at http://geeklawyer.org/
ccreport.pdf.
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generally known as the CC Baseline Rights.8" All CC licenses
provide these baseline rights:
Licensors retain their copyright; this explains why the baseline rights
do not apply to public domain offerings.
The licenses announce that fair use rights are not affected by the
license. This is a curious statement, as it should be assumed that any
clause that erodes acquired fair use or fair dealing rights should be
specified in the license.
Licensees will have to obtain specific permission to perform one of the
acts restricted by the license. For example, if the license does not allow
modification or adaptation of a work, this action could only be
performed with the permission of the owner. This seems to be a
redundant statement, as this is an action that is usually understood in all
licenses.
Copyright notices should not be removed from all copies of the work.
Every copy of the work should maintain a link to the license.
Licensees cannot alter any terms of the license. This seems to be yet
another redundant clause, as it should be understood that this is
common licensing practice.
Licensees cannot use technology to restrict access to the work. This
baseline right specifically forbids the use of technical protection
measures.81
Licensees are granted the right to copy, distribute, display, digitally
perform and make verbatim copies of the work into another format.
The licenses have worldwide application, last for the entire duration of
copyright (unless otherwise specified), and are irrevocable.8 2
It is important to note that the baseline definition of CC
licenses does not mention anything about modification or
adaptation of a work, does not deal with copyleft-like clauses
requiring the use of similar licenses to distribute the work, does not
mention attribution, and does not deal with the distribution of
copies for commercial purposes. This makes the basic Creative
Commons definition more akin the open source ideals than to the
80 See Creativecommons.org, Baseline Rights, http://creativecommons.org/
about/licenses/ [hereinafter Baseline Rights].
81 For more about technical protection measures, see Severine Dusollier,
Electrifying the Fence: The Legal Protection of Technological Measures for
Protecting Copyright, 21 EUR. INTELL. PROP. REv. 285 (1999).
82 See Baseline Rights, supra note 80.
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free software principles exemplified by the GPL.83 Nevertheless,
creators can choose a CC license that maintains all of the
restrictions mentioned, from all of the options offered. Authors
then can choose from the following options to generate their
license:84
Attribution: The work is made available to the public with the baseline
rights, but only if the author receives proper credit.
85
Non-commercial: The work can be copied, displayed and distributed
by the public, but only if these actions are for non-commercial
purposes.
No derivative works: This license grants baseline rights, but it does not
allow derivative works to be created from the original.
Share-Alike: This is based on copyleft principles. Derivative works
can be created and distributed based on the original, but only if the
same type of license is used, which generates a viral license.
86
It is possible to have licenses that combine several of these
options.87 The strongest (and most popular) CC license is the
Attribution Non-Commercial Share Alike License,88 which is the
license that most resembles the strongest copyleft software ones
(such as the GPL). All CC licenses are presented in three formats:
the first is a short and easy to read "Commons Deed," which
explains the terms and conditions of the license in a simple
manner; the second format is the "Legal Code," which is the full
license; and the third is the "Digital Code," which provides an
HTML version of the license89 that can be read by search engines
83 Guadamuz, supra note 10, at 333-34.
84 For more about the CC license elements, see http://creativecommons.org/
about/licenses.
85 Starting with Creative Commons version 2.5, the Attribution element is
factually a baseline right and not an element that can be chosen or not. See
Creativecommons.org, Choosing a License, http://creativecommons.org/
about/licenses/.
86 For more about the concept of viral contracts, see Margaret Jane Radin,
Humans, Computers, andBinding Commitment, 75 IND. L.J. 38 (2000).
87 However, the No Derivative and the Share-Alike elements are exclusive.
88 Version 2.0 can be found at Creative Commons.org, Commons Deed,
http://creativecommons.org/licenses/by-nc-sa/2.0/.
89 To be more specific, the code uses Resource Description Framework
("RDF") metadata. For more about RDF, see W3C Technology and Society
Domain, Resource Description Framework (RDF), http://www.w3.org/RDF/.
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and makes it easier to list the content in the Creative Commons
directory.
Creative Commons presents a very positive step towards the
wider distribution of non-proprietary technology. It is innovative,
thoroughly planned and smartly implemented. CC delivers open
access licenses in the digital domain with scalability, adaptability,
and ease of use for those unfamiliar with the legal issues involved
in licensing. CC also offers jurisdiction-specific versions of their
licenses to make them more valid in an international environment
and to respond to legal requirements in a given country.
The other major open content license is the GNU Free
Documentation License ("GFDL"), ° which is the FSF's non-
software license, and it is generally used to protect manuals and
other literature related to the FS movement. However, the GFDL
is also used in other open access projects, such as the free online
encyclopedia Wikipedia. The GFDL could be classified as an
open access license because it allows the copying, distribution and
adaptation of a work, provided the author complies with the
conditions included. These can be found in section two of the
license, which states:
You may copy and distribute the Document in any medium, either
commercially or noncommercially, provided that this License, the
copyright notices, and the license notice saying this License applies to
the Document are reproduced in all copies, and that you add no other
conditions whatsoever to those of this License.
91
This is an important point of the license, because it specifies
that it allows for the commercial use of the works. The GFDL
allows for the modification and translation of the work, provided
some specific sections are maintained or deleted; and all derivative
works must be licensed using the GFDL.92 This clearly means that
this is a copyleft license, perpetuating itself through this viral
clause. The viral nature of the license exists in section 4, which
states that "[y]ou may copy and distribute a Modified Version of
90 The full text of the license can be found at The GNU Operation System,
GNU Free Documentation License, ("GFDL") http://www.gnu.org/copyleft/
fdl.html.
91 Id. § 2.92 Id. §4.
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the Document ... provided that you release the Modified Version
under precisely this License . . . ."I' This is different from the
share-alike element in CC licenses, as these require only that the
work is released with a license that contains similar clauses and
rights.
The viral nature of the GFDL can be seen in practice through
the wide copying and dissemination of Wikipedia articles, which
are being used by many other open content providers, such as the
Free Dictionary." The articles found in this online resource have
to be licensed through the GFDL, allowing yet another third party
to copy them and use them in their website, provided that they use
the GFDL.
With so many creative works that may be subject to protection
by OA licenses, it should come as no surprise that there has been a
recent proliferation of licenses that allow commercial and non-
commercial content creators to adopt the non-proprietary open
access model. One such project is the Open Content License
("OPL"), a collaborative effort that sets a copyleft license,
ensuring that shared works will continue to remain free to
subsequent users.95 Similar efforts also include music creation via
the Open Audio License ("OAL"),96 the SCRIPT-ed Open License
("SOL"),97 and even Open Cola, the world's first copyleft fizzy
drink.98
Looking at the vibrant nature of the OA movement and the
publication of scientific materials in journals or through other
online means, it is clear that there are enough reasons to believe
that some part of the open science movement is doing quite well
93 Id.
94 See The Free Dictionary by Farlax, http://encyclopedia.thefree
dictionary.com/.
95 The license can be found at Open Content License ("OPL"),
http://www.opencontent.org/opl.shtml.
96 See Electronic Frontier Foundation-Defending Freedom in the Digital
World, http://www.eff.org/IP/Open licenses/eff oal.php.
97 See SCRIPT-ed Open Licence ("SOL"), http://www.law.ed.ac.uk/ahrb/
script-ed/sol.htm.
98 See Graham Lawton, The Great Giveaway, NewScientist.com, available at
http://www.newscientist.com/hottopics/copyleft/copyleftart.jsp.
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through the creation of growing body of work that is easily
accessible to researchers around the world. However, what
happens with scientific research that is not subject to publication?
Can scientific databases, archives, repositories, and patented
research be protected through open licenses?
B. Open Science Licenses
All of the aforementioned licenses have one thing in
common-they protect only works that are subject to copyright.
This is valuable when one considers that a significant amount of
basic scientific works is protected by copyright, particularly
academic journal articles and other literary works. This raises the
question of whether there can be open licenses that protect other
types of work in commercially viable fields like biotechnology and
health research-which are usually available through databases or
patents. This has proven to be difficult because, although there
have been many scientists and researchers advocating the
implementation of open licensing models to the scientific arena, it
is difficult to find a patent or database equivalent to the GFDL or
the Creative Commons licenses.
The reason for this is that the open license model works better
with copyright than with patents or databases. There are two main
reasons for this. First, copyright subsists in an original work as
soon as it is fixed in tangible form.9 9 Second, copyright does not
require any sort of registration to initiate protection, which means
that copyright "flows from the nib of a pen,"' 0 making it much
easier and cheaper to distribute through an open license as soon as
it is originated. On the other hand, works that require registration
to be subject to protection-such as patentable scientific
research-will be more difficult to distribute through an open
license, as several steps are required to distribute it with some sort
of permissible licensing model.
99 Berne Convention on Literary and Artistic Works, art. 2 (Sept. 9, 1886)
available at http://www.law.comell.edu/treaties/beme/overview.html.
1oo P. Cohen & T. Ryan, Copyright Law and the Internet, http://info.utas.edu.
au/docs/info/utas88/Peter.Cohen.html.
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Although the specific difficulties of providing a patent solution
will be discussed in more detail later, there has been some success
in applying limited open science solutions for databases and
patented works. These efforts are listed next.
1. Database Licenses
The importance of scientific databases for research is an issue
that has been well explored in the existing literature.'0 ' There can
be little doubt that in the information age, access to the vast
amount of scientific data stored in databases is of utmost
importance for researchers around the world. Access to a large
number of databases is offered for a fee by a vast array of service
providers and institutions."2 The growth in the number and the
economic importance of scientific databases has been accompanied
by increased concerns about the reuse of the data to provide further
works of commercial value. A report by the National Research
Council in the United States points out that:
Currently many for-profit and not-for-profit database producers are
concerned about the possibility that significant portions of their
databases will be copied or used in substantial part by others to create
"new" derivative databases. If an identical or substantially similar
database is then either redisseminated broadly or sold and used in direct
competition with the original rights holder's database, the rights
holder's revenues will be undermined, or in extreme cases, the rights
holder will be put out of business. Besides being unfair to the rights
holder, this actual or potential loss of revenue may create a disincentive
to produce and then maintain databases, thus reducing the number of
databases available to others.
10 3
This is of particular worry for those who are releasing genetic
data into the public domain, as described earlier. With publicly
available databases, commercial providers would find large
sections of readily available information that can be repackaged
101 See, e.g., William M. Gelbart, Databases in Genomic Research, 282
SCIENCE 659 (1998); Steve Lawrence & Lee Giles, Accessibility of Information
on the Web, 400 NATURE 107 (1999).
102 See NATIONAL RESEARCH COUNCIL, A QUESTION OF BALANCE: PRIVATE
RIGHTS AND THE PUBLIC INTEREST IN SCIENTIFIC AND TECHNICAL DATABASES,
40-51 (National Academy Press 1999).
103 Id. at 14.
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and resold as part of a commercial database. This possibility is
precisely what has prompted the calls to protect databases through
open source licenses."'
Despite the suggested application of the open source licenses
and ideals to databases, the actual application has not been met
with the enthusiasm that it deserves, which can be explained by
two main reasons. Firstly, most non-commercial information-
particularly in the field of biotechnology-is released into the
public domain. 5 This type of release is extremely useful for
future researchers, but it does little to curb the further
commercialisation of the data.
Secondly, the legal protection of databases is a subject that is
not fully harmonised at the international level, where different
jurisdictions apply a wide range of legal figures and levels of
protection to this type of intellectual work. For example, the
United States0 6 has been struggling with the application of
copyright law to the subject of databases by extending the
definitions of originality of a work. Earlier cases declared that the
mere rearrangement of information was not enough to prove
originality.0 7  Despite the originality requirement, there are
circumstances where the courts will award copyright protection to
databases due to the fact that there is enough originality in what is
done to the data.0 8 Europe has followed a different path by
embracing a "sweat of the brow" approach, where the work and
investment that goes into the gathering and arranging of the data is
rewarded, even if the data itself is not original,0 9 which is
'04 Maurer, supra note 9.
105 See, e.g., The GDB Human Genome Database, http://gdbwww.gdb.org/.
106 For a more complete analyses of U.S. database protection, see Jennifer
Askanazi et al., The Future of Database Protection in US. Copyright Law, 2001
DuKE L. & TECH. REv. 17 (2001); Jane Ginsburg, Copyright, Common Law, and
Sui-Generis Protection of Databases in the United States and Abroad, 66 U.
CIN. L. REV. 151 (1997).
107 In particular, see Feist Publ'n v. Rural Tel. Co., 499 U.S. 340 (1991).
108 This is made more evident in CCC Info. Serv. v. Maclean Hunter Mkt.
Rep., 44 F.3d 61 (2d Cir. 1994).
109 For more about database protection in Europe, see Catherine Colston, Sui
Generis Database Right: Ripe for Review?, 3 J. INFO. L. & TECH. (2001),
http://www2.warwick.ac.uk/fac/soc/law/elj/jilt/2001_3/colston/.
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particularly evident with the European Directive on the legal
protection of databases."' The Directive awards a sui generis right
to databases in which there has been a quantitative and qualitative
investment in obtaining or verifying the contained data.11
However, this picture is made more complex by the recent rulings
from the European Court of Justice, "2 which have eroded the
database right considerably. To further erode the European
database right, a report by the European Commission about the
application of the right has produced negative results, and even the
call to potentially eliminate it."3
It is precisely this complicated legal landscape that makes the
possible application of open source software models so difficult for
databases. It would seem possible that providers of scientific data
contained in a database compiled in a country that provides for the
copyright protection of databases (such as the United States), may
be able to issue their work through an open access license, perhaps
even a Creative Commons license. This would be possible
because in most jurisdictions databases are protected as literary
works."4 However, those providers would first have to be able to
be awarded protection in the first place, which is not always the
case, as evidenced by the originality standards prevalent in the
United States. In countries with a sui generis right, the licensing
would have to meet with the very high requirements of the recent
cases and the directive, which is not an easy task. According to
Waelde and McGinley:
110 DIRECTIVE 96/9/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL,
Mar. 11, 1996, O.J. (L 077) (1996).
... Id. at art. 7(1).
112 See Case C-203/02, British Horseracing Bd. v. William Hill, (2004)
E.C.R.; Case C-338/02, Fixtures Mktg. Ltd. v. Svenska Spel, (2004) E.C.R.;
Case C-46/02, Fixtures Mktg. Ltd v. OY Veikkaus, (2004) BAILII; Case C-
444/02, Fixtures Mktg. Ltd. v. OPAP, (2004) BAILII.
113 European Commission, First Evaluation of Directive 96/9/EC on the Legal
Protection of Databases (Dec. 2005), http://europa.eu.int/comm/internal_
market/ copyright/docs/databases/evaluationreport-en.pdf.
114 See, e.g., Copyright, Designs and Patents Act, 1988, § 3A (U.K.); Berne
Convention, supra note 99, at art. 2.5.
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Suffice it to say many questions remain over the extent to which
scientific databases might qualify for the sui generis right. Whereas at
first blush it might have appeared that many might fall out with the
necessary criteria, ... it is far too early to argue that the contents of
scientific databases fall into the public domain as a result of the ruling,
however much that might benefit scientists and the progress of
science.' 5
Taking into consideration all of these difficulties, it should
come as no surprise that a large amount of online scientific data is
still released into the public domain. Nevertheless, there are
indications that the solution may not be found in database
protection, but in contractual law. This is best evidenced by the
International HapMap Project Public Access License
("HPPAL"), 116 which is part of the HapMap genetic database
project. Unlike all other open licenses, the HPPAL does not assign
any intellectual property rights; it is an end-user agreement. The
data can only be accessed through following a registration process,
where the user is required to agree to terms and conditions before
gaining access to the certain parts of the HapMap genetic database.
The wording of the HPPAL makes it appear to be an
intellectual property assignment of rights (it is after all, called a
license), but it is not entirely clear what rights are held over the
data that is being offered." 7 The HPPAL is very careful not to
assign intellectual property rights, so it must be assumed that this is
just a user agreement where the author enters into the obligation to
comply with the terms and conditions set out in the document.
Specifically, paragraph three of the license states that: "[y]ou may
not access, copy, modify, sublicense, distribute or otherwise use
"5 Charlotte Waelde & Mags McGinley, Public Domain; Public Interest;
Public Funding: Focusing on the 'Three Ps' in Scientific Research, (2:1
SCRIPT-ed 83, 91 (2005)), available at http://www.law.ed.ac.uk/ahrb/script-
ed/vol2-1/3ps.asp.
116 To view the license, see International HapMap Project, http://www.
hapmap.org/cgi-perl/registration.
117 For more about genetic database protection, see Edward Baba, From
Conflict to Confluence: Protection of Databases Containing Genetic
Information, 30 SYRACUSE J. INT'L L. & COM. 121 (2003).
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the Genotype Database or the data contained in it except as
expressly provided under this License."'' 18
The most relevant part of the HapMap license is with regards
to future patent applications. Paragraph 2(b) of the license does
not allow the patenting of genetic information from the database,
with the exception of particular uses of sequences, provided that
the patent allows further use of the information obtained from the
database. The paragraph reads:
[Y]ou shall not file any patent applications that contain claims to
particular uses of any SNP, genotype or haplotype data obtained from
the Genotype Database or any SNP, haplotype or haplotype block
based on data obtained from, the Genotype Database, unless such
claims do not restrict, or are licensed on such terms that that they do not
restrict, the ability of others to use at no cost the Genotype Database or
the data that it contains for other purposes; .... 19
This is an attempt to provide a viral or share-alike element to
the agreement, as if the freedoms protected by this license are
protected in the future licensing of patented material. The
HapMap license offers an ingenious way of getting around the
problems of database protection enumerated above, as it relies on
contractual obligations rather than on intellectual property
protection, and may prove to be the way to go as far as database
licenses are concerned.
2. Patent Licenses
If the application of open licensing to scientific databases has
been minimal, the porting of OSS licenses to patented research has
been almost nonexistent and doubly problematic for reasons that
will be explored in more depth in the next section. Nevertheless,
there have been a handful of attempts to provide a workable
license for patented material, including a recent draft license.
One of the most promising efforts to provide a license has been
put forward by the Creative Commons project. Because Creative
Commons licenses are geared specifically towards creative works
subject to copyright protection, a new concept has been designed
118 HapMap Project Public Access License, supra note 116, at para. 3.
119 1d. at para. 2(b).
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to accommodate scientific research. This concept is the Science
Commons project, 120 which has been created to generate licenses
that will deal with intellectual property works that are not covered
by existing CC licenses. The project is ongoing at the time of
writing, and it has yet to produce a license draft available to the
public.
Another proposal is offered by Hubbard and Love, who explore
some alternative models of pharmaceutical research and
development to produce new medicines. 2' Their proposal uses the
existence of free software as an illustration that alternative
business models are viable, but unfortunately it fails to make the
point of how to translate OSS licensing ideals into the
pharmaceutical industry. Although Hubbard and Love's argument
may not connect directly with OA models, their suggestion is
important because they propose workable ways to fund the basic
research and to generate incentives to companies to distribute their
intellectual property to the public, which would be released
through open licenses. But the question remains, which open
licenses?
The answer to the question of licenses may lie in the
aforementioned CAMBIA project. One of the most important
parts of the objectives of CAMBIA is the use of open source ideals
to generate a protected commons for researchers in the life
sciences. This is done through a couple of licenses-the BiOS
Plant Enabling Technology License and the BiOS Genetic
Resource Technology License. These schemes can be used for
specific types of patented material. According to the project, the
licenses work like this:
Instead of royalties, BiOS licensees must agree to legally binding
conditions in order to obtain a license and access to the protected
commons. These conditions are that improvements are shared, and that
licensees cannot appropriate the fundamental "kernel" of the
technology and improvements exclusively for themselves. Licensees
120 Science Commons, Welcome to Science Commons,
http://creativecommons.org/projects/science/proposal.
21 Tim Hubbard & James Love, A New Trade Framework for Global
Healthcare R&D, http://www.pubmedcentral.nih.gov/picrender.fcgi?artid =
340954&blobtype=pdf.
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obtain access to improvements and other information, such as
regulatory and biosafety data, shared by other licensees. To maintain
legal access to the technology, licensees must agree not to prevent other
licensees from using the technology in the development of different
products.
22
The core concept of the BiOS Licenses is that they will be able
to provide patented research with a permissive license that operates
within OSS and open access principles. However, this is easier
said than done, and the existing drafts demonstrate just how
difficult it is to word open source patent licenses. Earlier drafts
consisted of a single document that covered different types of
patented technologies, particularly "Crop Molecular Enabling
Technologies and associated patents, patent applications, know-
how, data, materials, and business, technical, economical and
manufacturing information."'23 However, the complicated nature
of the subjects prompted a forking of the license to cover two
different technologies, such as plant-enabling technologies and
genetic resources technologies. While the subject and the specific
application of both licenses are different, the legal principles and
structure of both are the same, so they will be covered in the same
way.
The first important common element of the licenses is that the
patent owner always retains control over the technology, and what
is established is a permissive chain of distribution. However, there
is a possibility that that the licensor could be a licensee himself.
The reason for this is because the BiOS Licenses contain a viral
clause that allows licensees to sub-license the material, as long as
the same rights that are contained in the license are preserved in
the vertical agreement.2 4 Paragraph 2.1 is the license grant, which
gives licensees: "a worldwide, non-exclusive, royalty-free right
and license to make and use the IP & Technology for the purpose
122 CAMBIA, Biological Innovation for Open Science, About BiOS
(Biological Open Source) Licenses, http://www.bios.net/daisy/bios/398.
123 CAMBIA, Biological Innovation for Open Science, About BiOS
(Biological Open Source) Licenses, supra note 122, at BIOS License version
1.1.
124 CAMBIA, Biological Innovation for Open Science, About BiOS
(Biological Open Source) Licenses, supra note 122, at para. 3.1 and subsections
of both licenses.
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of developing, making, using, and commercializing BiOS Licensed
Products without obligation to CAMBIA, including a right to
sublicense .... ,,2
Similarly, improvements to the patented technology are
allowed as long as those are communicated to licensor, along with
all improvement patent applications.126 When compared to existing
open source and open access licenses, the elements and clauses
present in the BiOS License make it akin to a CC Attribution
Commercial Share Alike license.
This is a worthwhile effort to create a viable "open source"
license for patented materials. However, even in its draft stages it
is easy to see that the language seems stretched and unclear in
many instances-something that could turn away some potential
licensors who could find the complex explanation of the terms and
conditions difficult to navigate. Another question that arises from
the draft is that it is not very clear what would be the role of the
initial licensor and his place in a lengthy chain of sub-licensees.
Paragraph 2.1.2 for example, states that:
BiOS LICENSEE shall be responsible to ensure in said sublicenses that
any Improvements produced by sublicensees are considered to be
Improvements hereunder and that such sublicenses require the
performance of all applicable obligations due to CAMBIA and other
BiOS Licensees under this Agreement and any associated Agreements.
BiOS LICENSEE shall provide a list of sublicensees to CAMBIA in
writing at least once a year, which CAMBIA is entitled to post in
CAMBIA's Protected Commons website (BioForge) or make available
to BiOS Licensees.
127
Does this really mean that the sub-licensee has some duty of
care with regards to the actions of subsequent sub-licensees? How
can such responsibility be exercised? Does this give the licensee
the same rights and obligations as the licensor? What about the
obligation to notify the licensor of any improvements? It would
"' CAMBIA, Biological Innovation for Open Science, About BiOS
(Biological Open Source) Licenses, supra note 122, at para. 3.1 and subsections
of both licenses.
12 CAMBIA, Biological Innovation for Open Science, About BiOS
(Biological Open Source) Licenses, supra note 122, at para. 3.2 of both licenses.
127 CAMBIA, BIOS Plant Enabling Technology License, http://www.cambia.
org/daisy/PELicense/751/3 82.
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seem that this would fall into the obligations of the sub-licensee.
Is the sub-licensee in any obligation to notify the original licensor?
It has been pointed out that the BiOS License is a work in
progress and requires more fine tuning to be ready for
consumption, so no further analysis of the drafts is wise at the
moment when the final texts may change considerably in the near
future. Nevertheless, the draft licenses as they exist are
tremendously complex, they represent a considerable legal
document, which small and medium research facilities are
supposed to sign to with little or no legal assistance. The patent
filed is subject to minute legal technicalities, and adding a
complicated license to the equation may increase the legal
uncertainty that already exists. Research centres may be tempted
to simply stay away from all open licensing efforts to reduce their
liabilities. But there are other inherent problems with patent
licensing that make the porting of OSS extremely unlikely.
3. Trouble with Patents
The difficulties with the one existing patent license scheme and
the lack of other open science licenses indicates that there appears
to be an inherent problem in porting a licensing model that has
been designed to work with copyright into a system that would
have to work with patents.
There can be little doubt that patents offer the strongest short-
term protection of technologies emanating from costly scientific
research.'28 It has several advantages in order to protect certain
technologies, particularly because some types of research may
produce outputs that would not be suitable for copyright
protection. While this is precisely how the commercial world
operates, those interested in making their work available to the
public under some sort of open license model will have to do it by
protecting their work, as the entire system is based on the threat of
infringement suits brought against those who had not shared the
work according to the required clauses.
128 See Mansfield, supra note 4.
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The problem then for some institutions wanting to release their
research is that they will have to obtain a patent in order to license
it. This can prove to be an expensive endeavor. Some studies
estimate that an average biotechnology patent application could
cost an average of $7,500 in the United States alone.129 Because
patents must be applied separately in each jurisdiction where they
will be exploited, 3 ' the costs for a small research institution could
be prohibitive. Even when the patent has been obtained, the
enforcement of patents is where the costs are steeper. The cost of
defending a patent in the United States where the dispute is less
than a million dollars can range from $300,000 to $750,000.131
This means that even if a research institution obtains a patent to
protect their research, the right holders would find it extremely
expensive to defend their intellectual property against misuse-
particularly considering that those likely to use open source
licenses may be small research institutions, or even individual
researchers.'32 The problem would be more pronounced for
researchers in developing countries, as they would possibly have to
enforce patents abroad.
The sheer costs involved could be enough to dissuade small
and medium research facilities to stay clear of the potential
liabilities involved with the patent system, and continue releasing
information through more traditional means. Nevertheless, there
may be a viable solution for the problem of the enforcement of
patents held by individual organisations. The problem of
enforceability of OSS licenses is similar to what has been
described in the previous paragraphs. In software, many small
software developers do not have the resources to enforce their
copyrights. For that purpose, the FSF recommends that all those
129 For more about the economics of the patent system, see ADAM JAFFE &
JOSH LERNER, INNOVATION AND ITS DISCONTENTS: How OUR BROKEN PATENT
SYSTEM Is ENDANGERING INNOVATION AND PROGRESS, AND WHAT TO Do
ABOUT IT, 64-69 (2004).
130 There are, however, some ways around this, such as the existence of the
European Patent Office, and the tools provided by the Patent Cooperation Treaty
("PCT").
131 JAFFE & LERNER, supra note 129.
132 This assumption is an extrapolation from what is taking place in the use of
open licenses in software and the creative industries.
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programmers using their licenses should assign copyright of their
works to the FSF because in that way they can enforce the license
better in case of infringement. 33 This scheme could be replicated
in open science licenses, and has been accepted by CAMBIA as
one of its potential roles by stating that BiOS will serve as "a
collective defense of the commons and non-assertion of IP rights
against other members of the commons."'34 Therefore, collective
organisations could be in charge of the enforcement of research
held by individuals.
Another possible problem for the use of open licenses of
patented technology is that it could be argued that open licenses
are incompatible with prevalent patent policy goals. An often
stated goal of a patent system is to encourage the distribution of
inventions through the utilitarian justification that allows for the
economic reward.'35 An open license model might clash with this
objective because it would stop inventors from being able to
economically recuperate investments in future research related to
the patented one, particularly if a non-commercial viral license is
used. For example, imagine a patented gene sequence that has
been licensed through a copyleft license containing non-
commercial viral restrictions. Researchers who would want to
patent improvements based on the licensed sequence and then
exploit them commercially may find that they would be in breach
of their licenses, as they would not be able to sub-license their
work commercially because of the viral restrictions. But what if
those researchers incurred considerable expenses to produce the
improvements? They would have to license their research using a
non-commercial clause as well, which would defeat the utilitarian
justification for patents. The BiOS License does not appear to
have this problem because it allows commercial use of the patented
technology, so there may be a case that there cannot be a
non-commercial open license for patents.
133 Eben Moglen, Why the FSF gets copyright assignments from contributors,
http://www.gnu.org/copyleftl/why-assign.html.
134 Biological Innovation for Open Science, Frequently Asked Questions-
BIOS Licenses, http://www.bios.net/daisy/bios/BiOS-licenses/bioslicense_
faq.html.
135 Feldman, supra note 14, at 120.
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The apparent incompatibility of the patent system with open
source is well known in the groups that advocate for its
implementation. The statement of purpose of the Science
Commons project enumerates some of the problems faced by the
project in trying to translate the CC ideals into working licenses for
works that rely on patent protection. 3 6 The Science Commons
proposal goes as far as to point out that "[m]any of the things that
we have learned in forming the Creative Commons do not translate
completely to the world of science policy. We dealt primarily with
copyright-here the issues would also involve patent and trade
secret."'37
The potential incompatibility between patents and open source
licenses is difficult to resolve. Even with the early drafts of the
BiOS Licenses, the nature of the patent system seems to offer
insurmountable obstacles to the possible adoption of a viable open
science license dealing with patented technology. Those industries
that are willing to incur the cost of expensive research will want to
see their efforts rewarded, and a large patent portfolio will give
research-heavy institutions an excellent bargaining position when
dealing with other competitors within the industry. The race to
decode the human genome has served to demonstrate that there are
significant economic interests at play, and this is a fact that will not
go away overnight. This is why the best option for smaller
research facilities and public interest oriented institutions is to
disseminate works through releases into the public domain. This
type of dissemination has the effect of widening the accessibility of
the research by other small industries. Another effect of the
release of materials into the public domain would be to pre-empt
future patent applications, because the research has already been
made public. Eisenberg explains this tactic:
In addition to making it difficult for publicly-funded investigators and
their institutions to file timely applications for patents, the Bermuda
rules also lead to the prompt creation of "prior art" that could
potentially defeat patent claims based on similar DNA-sequencing
136 Joy Davidson, Digital Curation Centre (DCC), Creative Commons:
Establishing a Science Commons, http://creativecommons.org/science/about/
scbackground.
137 Id.
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efforts in the private sector. No one can get a patent on something that
was already publicly disclosed before the patent claimant discovered
it. 138
Despite this seemingly watertight solution, there is still a real
potential that the information that has been made available for free
could be copied and then used to make patent applications about
that same material. The chaotic state of patent applications in
areas such as software and biotechnology'39 provides a warning
that patent offices cannot be trusted in identifying whether a patent
application is innovative, or if it is based on significant prior art.
It would be fair to assume that there are too many problems,
and it could be suggested that perhaps open science should be
scrapped-at least in open science for patents. The lack of licenses
at the moment makes the possible implementation difficult, while
the few efforts that have been proposed still seem to fall short.
Even the strongest proponents of open science and open
biotechnology recognise that the movement cannot go forward
without viable licenses. Hope comments that:
Key issues for advancing the open source biotechnology analysis will
be developing open source patent licenses and other licenses
appropriate for biotechnological subject matter, assessing the
importance of higher capital costs in biotechnology development and
establishing whether or not there exist secondary markets for
biotechnology services or other commercial offerings that might
support business models along the lines that have proved successful in
the software context. 1
40
It is perhaps time to look at different options. Those who
believe in ensuring wider access to scientific research and
technology should not be daunted by the difficulties encountered,
as there may be other solutions that can provide a viable manner to
138 Rebecca Eisenberg, The Public Domain in Genomics (2000),
http://www.law.nyu.edu/ili/conferences/freeinfo2000/abstracts/eisengberg.html.
139 For more about patent abuse in these two fields, see Eloise Gratton, Should
Patent Protection Be Considered for Computer Software-Related Innovations, 7
COMP. L. REv. & TECH. J. 223 (2003); Andrews, supra note 57; JAFFE &
LERNER, supra note 129.
140 Janet Hope, Open Source Biotechnology?, http://rsss.anu.edu.au/-janeth/
OSBiotech.html.
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harness the creative and developmental strengths of the open
source model with other ways of dissemination.
V. SPECIFIC PROPOSALS
Apart from the CAMBIA License, the tackling of the patenting
problem is short in suggestions, as most of the proponents of the
open science and open biotechnology solutions for scientific
research usually fail to even tackle the question of the potential
problems presented by patents."' The solution to the problem may
not be in the drafting of new complicated licenses, but in looking
elsewhere for inspiration as to new manners of allowing wider
access to patented technologies.
In this line, Cukier has suggested that this is not an issue of
licenses, but rather suggests that the patenting problems could be
overcome through changes in government policy by applying
existing national interest patent defenses that are already in use in
the United States in the area of defense and health.'42 He
comments that:
US-funded research enables the government to use the resulting
technology on a royalty free basis. In the case of the Bayh-Dole Act,
the government has 'march-in' rights to take control of a patent it does
not believe it being sufficiently exploited. More broadly, the US and
its contractors can't be prohibited from using patented technology as a
matter of law .... 143
However, this proposal seems to fall short, as it would be very
difficult to convince governments in today's IP protectionist
environment that there should be some sort of public policy that
permits the licensing of some works.
Another novel solution would be to continue using the tried
and tested OA and OSS licenses, but to change the clauses to read
more generically. For example, instead of using "copyright," the
licenses could use "intellectual property," which would cover
141 Some examples have already been mentioned. For other examples, see
Stephen Maurer, Arti Rai & Andrej Sali, Finding Cures for Tropical Diseases:
Is open source an answer, http://ist-socrates.berkeley.edu/-scotch/ PLOS.pdf.
142 See Cukier, supra note 12.
143 See Cukier, supra note 12.
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patents. However, this seems like an ad hoc patch that fails to
provide a real answer to the problems highlighted. This could be
solved by using existing software licenses that mention patents.
There is one such license: the Apache License (version 2.0),'
which contains a patent assignment clause that reads:
Subject to the terms and conditions of this License, each Contributor
hereby grants to You a perpetual, worldwide, non-exclusive, no-charge,
royalty-free, irrevocable (except as stated in this section) patent license
to make, have made, use, offer to sell, sell, import, and otherwise
transfer the Work, where such license applies only to those patent
claims licensable by such Contributor that are necessarily infringed by
their Contribution(s) alone or by combination of their Contribution(s)
with the Work to which such Contribution(s) was submitted. If You
institute patent litigation against any entity (including a cross-claim or
counterclaim in a lawsuit) alleging that the Work or a Contribution
incorporated within the Work constitutes direct or contributory patent
infringement, then any patent licenses granted to You under this
License for that Work shall terminate as of the date such litigation is
filed.
145
This seems like a viable possibility, as Apache is the dominant
web server around the world, with seventy percent of all websites
on the net served by Apache software.'46 The data suggests that a
direct translation of the Apache license to the realm of patented
technology would be possible. However, there should be a
cautionary word regarding the Apache License, and it is the fact
that it is not the predominant open source license. Out of more
than 64,000 open source projects listed in the SourceForge portal,
only 344 use this license. 147
Recent developments have suggested that there may be another
way, and that strict licenses are not needed to provide a common
pool of accessible scientific data and technology. IBM has made
the headlines of every major technology-related news publication
'44 The license can be found at Open Source, Apache License, version 2.0.,
http://www.opensource.org/licenses/apache2.0.php.
145 id.
146 According to Netcraft's web server survey for March 2005. See Netcraft,
March 2005 Web Survey Finds 60 Million Sites, http://news.netcrafi.com/
archives/webserver-survey.html.
147 Data gathered from SourceForge's Software Map. See SourceForge's
Software Map, http://sourceforge.net/softwaremap/trove-list.php?form_cat = 14.
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by stating that it will not enforce 500 software patents that it owns
if they are used by open source software projects.'48 This
unprecedented move has been achieved through a clever use of
contract law. IBM has published a legally-binding promise not to
enforce a number of their patents to those software projects that are
released to the public through a license approved by the Open
Source Institute.'49  This element of IBM's pledge is very
important, as it gives a tight definition of what will be an open
source project. The definition reads:
Open Source Software is any computer software program whose source
code is published and available for inspection and use by anyone, and is
made available under a license agreement that permits recipients to
copy, modify and distribute the program's source code without
payment of fees or royalties. All licenses certified by opensource.org
and listed on their website as of 01/11/2005 are Open Source Software
licenses for the purpose of this pledge.' 50
The document goes on to promise that IBM will not assert any
of the listed patents in the United States, or its counterparts
worldwide, against open source projects, defined as above.5 The
document ends with a list of the 500 patents. This announcement
should be met with some skepticism, as IBM has a considerable
software patent portfolio, and was awarded more than 3000 patents
in 2004 alone. 52 One should also be skeptical about the possible
legal validity of such promise.
The main question about the validity of the pledge is centred
on the question of its classification within contractual law. In this
document, IBM is making a unilateral promise that stands on the
assumption that it can be met by those who qualify as an open
source developer. This promise does not require an obligation per
se, it simply promises not to sue a group of people that fulfill
148 IBM frees 500 software patents, BBC NEws, Jan. 11, 2005, available at
http://news.bbc.co.uk/l/hi/technology/4163975.stm.
49 The list of approved licenses can be found at Open Source, The Approved
Licenses, http://www.opensource.org/licenses/.
150 IBM, IBM Statement of Non-Assertion of Named Patents Against OSS
(2005), http://www.ibm.com/ibm/licensing/patents/pledgedpatents.pdf.
151 id.
152 IT Facts, IBM, Matsushita, Canon and HP received the most US patents in
2004, http://www.itfacts.biz/index.php?id=P2370.
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certain characteristics. In this manner, it is not so different than a
retailer that promises to give free CDs to those who bring a coupon
to their store. The issue of unilateral promises is an area of the law
that varies from one jurisdiction to another. In some Common
Law systems, the question of unilateral promises has often been
dealt with as an issue of contract formation and consideration. 5
3
However, the landmark case of Carhill v. Carbolic Smoke Ball
Company"' established that a unilateral promise that is accepted
through the performance of an act is valid. Scotland does not have
a problem with acceptance; therefore unilateral promises are much
less of an issue and have to be considered generally valid.' Other
European countries have different rules for the acceptance of
unilateral promises,"6 but countries like Germany'57 and France"'
allow some models of obligations arising from unilateral promises.
This tends to give strength to the validity of IBM's promise.
IBM's non-enforcement promise is a very practical and
seemingly valid solution that can be applied to all other sorts of
patents, and it could prove to be an effective tool to solve the
problematic application of OSS models to patented technologies.
This could work for individual scientists or research institutions
that are interested in maintaining their intellectual property, but
that want to allow access to their patented material to specific
recipients. These institutions could publish their own promise not
to assert their patent portfolio, or a selected list of patents, as long
as the users fall into a specified category of beneficiaries. It is
important that the patent owner identifies clearly the intended users
of the technology, and defines it unequivocally in the document. A
153 See, e.g., Paul Mitchell & John Phillips, The Contractual Nexus: Is
Reliance Essential, 22 OxFORD J. LEGAL STUD. 115, 118-24(2002).
154 [1893] 1 QB 256 (C.A.).
155 There are a few exceptions, such as the requirement that the promise
should be in writing. For more about promises in Scotland contract law, see
HECTOR MACQUEEN & J.M. THOMSON, CONTRACT LAW IN SCOTLAND, 63-69,
(2000).
156 For more about European applicability of unilateral promises, see THE
ENFORCEABILITY OF PROMISES IN EUROPEAN CONTRACT LAW, (J. Gordley ed.,
Cambridge Univ. Press 2001).
157 Burgerliches Gesetzbuch [BGB] § 657.
158 As shown in Cass. Civ. ire, (Oct. 16, 1995).
[VOL. 7: 321362
OPEN SOURCE LICENSING
promise that allows use in developing countries would be useless,
unless it is accompanied by a clear definition of what constitutes a
developing country, and what sort of users in those countries
would benefit from the pledge. A possible clause could thus read:
"this pledge will benefit researchers based in a Least Developed
Country as defined by the United Nations Conference for Trade
and Development;" or "for the purpose of this promise, developing
country will be defined as a country that is listed as having low
human development in the 2004 Human Development Report by
the United Nations Development Programme." Another important
element to add is that the patent owner could generate a web form
where users who fall into the definition could register as such,
which would have the added benefit that the owner would have a
better idea of who is using the technology.
One of the main advantages of the use of a unilateral promise is
that it helps to focus the access to scientific research to those who
the patent owner would not consider to be a commercial threat or
potential competition, which would erase some of the concerns
about the possible incompatibility of open source models with the
expenses and commercial value of research. This solution is not a
licensing scheme; therefore, it eliminates some of the more
complex contractual chains of distribution that can be found in
viral contracts. Researchers could also gain in the knowledge that
there will be a certain amount of knowledge that can be used
without fear of infringement.
VI. DRAFT PROMISE
Preamble
[This space can be used to indicate the purpose and the
rationale behind the promise]
Definitions
[This space will contain a series of strict definitions of the
beneficiaries. Some examples are provided]
"Technology": the list of patents included in the Annex.
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"Owner": The patent owner, [INSERT NAME].
"Beneficiary": Any organisation that is a listed participant
of BioForge projects as of [INSERT DATE].
Promise
The Owner hereby promises not to enforce any of the listed
Technology against Beneficiaries that have registered their
intent to use the Technology at the following address [INSERT
FORM ADDRESS].
Warranty
The Owner certifies that the Technology is owned by
him/her [or that it has specific permission to issue the promise].
The Owner also certifies that the Technology is not subject to
litigation as of [INSERT DATE]. The Owner presents the
Technology "as is," and makes no warranty as to the accuracy
of the information contained in the patent application.
Limitation of Liability
Subject to any liability which may not be excluded or
limited by law, the Owner will not be held liable for incidental,
consequential, or indirect loss or damage howsoever and
whenever caused to the Beneficiary.
Annex
[Table of patents, listing patent number, awarding office,
beneficiary and title (or brief description)]
VII. CONCLUSION
The issue of access to scientific research is becoming one of
the most important issues of our time. The direction of the flow of
knowledge rests greatly on the problem of the ownership of
technology. One of the grandest ideas in recent years is the use of
intellectual property tools to protect certain parts of human
knowledge, something that is managing to generate shared
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knowledge, a common pool of technology and research that can be
accessed by all; a common space where the information flows with
fewer restrictions than in an entirely proprietary model.
This common space has already been experimented with and
explored within the free software and open source software
communities. The non-proprietary software experiment has
demonstrated that open development models are viable and
sometimes even commercially successful. Amongst these models,
one of the most interesting licenses is that offered by so-called
copyleft licenses, those licenses that allow software to be
transferred with the insurance that the source code will remain
open, with the caveat that anyone who redistributes the software,
with or without changes, must pass along the freedom to further
copy and change it.
However, software development is not the only area in which
this licensing model could be applied. The viral nature of copyleft
licenses has generated a considerable amount of interest in circles
that transcend software development. The idea of sharing
materials is not new, and has been made more evident by the
chaotic and sometimes anarchic nature of the Internet. However,
shared materials tend to suffer from the possibility of third parties
who use the freely acquired information to turn them into
proprietary works. That is why many different organisations are
turning to the copyleft model to protect works that are being freely
shared online.
This article has explored the application of non-proprietary
software licenses to scientific research-particularly academic
publications, scientific databases, and patented technologies. To
do this, several different licensing models have been explored. It
is clear that copyright materials are well suited for this experiment,
and the area of scientific publications shows special promise for
the future. Unfortunately, other types of scientific outputs present
more challenges to those involved. Costly research and
development have produced entire fields of study that are not
suitable to adopt the open source ideals. Although the trailblazing
efforts of CAMBIA, HapMap and the BiOS Licenses must be
applauded and recognised, the author feels that there is much to be
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done to ensure access to expensive technology to the widest
possible audience. IBM's unilateral promise gives researchers a
model to emulate to ensure this objective. It is feasible to apply
this document to almost all investigation efforts that result in a
patent.
The author recognises that this is just a draft proposal, but it is
hoped that others can continue to add to this idea if it is found to be
useful.'59 In the best spirit of the Bazaar, and paraphrasing Linus
Law, given enough eyeballs, all license bugs are shallow.
159 Comments about this draft are welcome, please send them to
a.guadamuz@ed.ac.uk.
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